Skip to main content
PeopleBio, Inc. logo

PeopleBio, Inc. — Investor Relations & Filings

Ticker · 304840 ISIN · KR7304840002 KO Manufacturing
Filings indexed 250 across all filing types
Latest filing 2021-11-26 Capital/Financing Update
Country KR South Korea
Listing KO 304840

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases. The company's primary focus is on degenerative brain disorders, particularly Alzheimer's disease. It develops blood-based diagnostic kits and immunoassays designed for early detection. By providing tools for early diagnosis, PeopleBio aims to facilitate timely intervention and treatment, thereby improving patient outcomes for these conditions.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing titled '전환사채권 발행결정 정정신고' (Correction Report for Convertible Bond Issuance Decision). It details specific changes to the terms of a previously announced convertible bond issuance, including adjustments to the issuance amount, maturity date, and conversion price. This falls under the category of capital structure and financing updates, specifically related to debt instruments.
2021-11-26 Korean
주요사항보고서(소송등의제기)
Legal Proceedings Report Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding the filing of a lawsuit (소송 등의 제기). Specifically, it details a 'Prohibition of Convertible Bond Issuance' injunction (전환사채발행금지가처분) filed against the company. Since it pertains to legal proceedings and litigation, it falls under the Legal Proceedings Report category.
2021-11-26 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) between PeopleBio and All Eights Pte Ltd. It details the contract value, duration, and terms. Since this is a specific corporate announcement of a material business contract that does not fit into the other specialized categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-11-08 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company (PeopleBio) regarding a 'Capital Increase Decision' (유상증자결정). It details the issuance of new shares, specifically third-party allocation, including conversion rights, payment dates, and the purpose of the funds. This falls under the category of announcements regarding new share issues or capital changes.
2021-10-13 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a formal 'Correction Report' (정정신고) regarding a previously filed 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It details specific changes to the bond's maturity date, payment dates, and conversion periods. In the context of Korean corporate filings (DART system), this is a 'Major Disclosure' (주요사항보고서) related to capital financing. Since it is a formal regulatory filing detailing changes to a capital structure (convertible bonds), it falls under the 'Capital/Financing Update' category.
2021-10-13 Korean
전환가액의조정(제4회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) issued by the company. It details the change in conversion price, the number of convertible shares, and the calculation methodology based on market price fluctuations. This type of disclosure regarding capital structure and debt-to-equity conversion terms falls under the 'Capital/Financing Update' category.
2021-09-29 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.